Who are CQ and PQ starting on Day 42's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cq-and-pq-starting-on-day-42.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

CQ and PQ starting on Day 42 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CQ and PQ starting on Day 42 (CQ and PQ starting on Day 42) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimalarial agents. Area: Infectious Disease.

phase 3 Antimalarial agents Parasite heme polymerase (CQ); hypnozoite mitochondrial electron transport (PQ) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

CQ and PQ starting on Day 42 (CQ and PQ starting on Day 42) — Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. CQ (chloroquine) and PQ (primaquine) are antimalarial agents that inhibit parasite DNA replication and metabolism, with PQ also targeting hypnozoites to prevent relapse.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
CQ and PQ starting on Day 42 TARGET	CQ and PQ starting on Day 42	Fundação de Medicina Tropical Dr. Heitor Vieira Dourado	phase 3	Antimalarial agents	Parasite heme polymerase (CQ); hypnozoite mitochondrial electron transport (PQ)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimalarial agents class)

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). CQ and PQ starting on Day 42 — Competitive Intelligence Brief. https://druglandscape.com/ci/cq-and-pq-starting-on-day-42. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab